Myosotis compositum Injektionslösung (i.m., i.v., s.c.)
Country: Շվեյցարիա
language: ֆրանսերեն
source: Swissmedic (Swiss Agency for Therapeutic Products)
PIL active_ingredient:
araneus diadematus ex animal totum D6 (SV), calcium phosphoricum (HAB) D12, equisetum hiemale (HAB) D4 , ferrum jodatum D12 (HAB 6), fumaria officinalis (HAB) D4, gentiana lutea (HAB) D5, geranium robertianum (HAB) D4, juglans regia ex fructus viridi cortices et folia D3 (HAB 3a), levothyroxinum D12 (HAB 6), myosotis arvensis (HAB) D3, nasturtium officinale (HAB) D4, natrium sulfuricum (HAB) D4 (HAB 5a), pinus sylvestris (HAB) D4, scrophularia nodosa (HAB) D3, smilax (HAB) D6, teucrium scorodonia (HAB) D3, veronica officinalis (HAB) D3, natrium
MAH:
ebi-pharm ag
INN:
araneus diadematus ex animal totum D6 (SV), calcium phosphoricum (HAB) D12, equisetum hiemale (HAB) D4 , ferrum jodatum D12 (HAB 6), fumaria officinalis (HAB) D4, gentiana lutea (HAB) D5, geranium robertianum (HAB) D4, juglans regia ex fructus viridi cortices et folia D3 (HAB 3a), levothyroxinum D12 (HAB 6), myosotis arvensis (HAB) D3, nasturtium officinale (HAB) D4, natrium sulfuricum (HAB) D4 (HAB 5a), pinus sylvestris (HAB) D4, scrophularia nodosa (HAB) D3, smilax (HAB) D6, teucrium scorodonia (HAB) D3, veronica officinalis (HAB) D3, natrium
pharmaceutical_form:
Injektionslösung (i.m., i.v., s.c.)
composition:
araneus diadematus ex animal totum D6 (SV) 0.55 mg, calcium phosphoricum (HAB) D12 0.55 mg, equisetum hiemale (HAB) D4 0.55 mg, ferrum jodatum D12 (HAB 6) 1.10 mg, fumaria officinalis (HAB) D4 0.55 mg, gentiana lutea (HAB) D5 0.55 mg, geranium robertianum (HAB) D4 1.10 mg, juglans regia ex fructus viridi cortices et folia D3 (HAB 3a) 0.55 mg, levothyroxinum D12 (HAB 6) 0.55 mg, myosotis arvensis (HAB) D3 0.55 mg, nasturtium officinale (HAB) D4 1.10 mg, natrium sulfuricum (HAB) D4 (HAB 5a) 0.55 mg, pinus sylvestris (HAB) D4 0.55 mg, scrophularia nodosa (HAB) D3 0.55 mg, smilax (HAB) D6 0.55 mg, teucrium scorodonia (HAB) D3 0.55 mg, veronica officinalis (HAB) D3 0.55 mg, natrii chloridum, aqua ad iniectabile, aqua ad iniectabile, pro vitro corresp. natrium 4.06 mg.
class:
B
therapeutic_group:
Les Médicaments Homéopathiques
therapeutic_area:
Zulassung mit reduziertem Dossier ohne Indikation nach Art. 25 Abs. 1 KPAV (SR 812.212.24)
authorization_status:
zugelassen
authorization_date:
2013-08-12
